Cargando…

Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment

INTRODUCTION: Preferences for diabetes treatment-related attributes may be significant in diabetes management. However, there is a lack of evidence on patient preferences for diabetes in China. METHODS: A large-scale questionnaire survey was conducted in the hospitals of mainland China. Participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yuankai, Huang, Qixiang, Xu, Ailin, Lu, Mengqing, Xi, Xiaoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846300/
https://www.ncbi.nlm.nih.gov/pubmed/35178370
http://dx.doi.org/10.3389/fpubh.2021.782964
_version_ 1784651832441700352
author Huang, Yuankai
Huang, Qixiang
Xu, Ailin
Lu, Mengqing
Xi, Xiaoyu
author_facet Huang, Yuankai
Huang, Qixiang
Xu, Ailin
Lu, Mengqing
Xi, Xiaoyu
author_sort Huang, Yuankai
collection PubMed
description INTRODUCTION: Preferences for diabetes treatment-related attributes may be significant in diabetes management. However, there is a lack of evidence on patient preferences for diabetes in China. METHODS: A large-scale questionnaire survey was conducted in the hospitals of mainland China. Participants' preferences for six attributes were evaluated via a discrete choice experiment (DCE) using the conditional logit model. Patients' willingness to pay (WTP) for each attribute was calculated based on the cost attribute. RESULTS: The sample consisted of 709 patients (male 51.9%; female 48.1%). The results of the model indicated that patients' preference weight (PW) of days on which the blood glucose level is under control per week was the highest (1.41), and the PW of blood glucose monitoring frequency was the lowest (0.642). Patients were generally willing to pay for improvements in their type 2 diabetes mellitus (T2DM) treatment, and they had relatively higher WTP to avoid the blood glucose level within a normal value of 1 day/week (¥176.01) and also to avoid the frequency of hypoglycemic events within the range of 1–2/month (¥144.53). CONCLUSION: The number of days on which the blood glucose level is under control per week is the most important attribute in the treatment choice for patients with T2DM in China, followed by the frequency of hypoglycemic events, medication regimen, weight change, and blood glucose monitoring.
format Online
Article
Text
id pubmed-8846300
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88463002022-02-16 Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment Huang, Yuankai Huang, Qixiang Xu, Ailin Lu, Mengqing Xi, Xiaoyu Front Public Health Public Health INTRODUCTION: Preferences for diabetes treatment-related attributes may be significant in diabetes management. However, there is a lack of evidence on patient preferences for diabetes in China. METHODS: A large-scale questionnaire survey was conducted in the hospitals of mainland China. Participants' preferences for six attributes were evaluated via a discrete choice experiment (DCE) using the conditional logit model. Patients' willingness to pay (WTP) for each attribute was calculated based on the cost attribute. RESULTS: The sample consisted of 709 patients (male 51.9%; female 48.1%). The results of the model indicated that patients' preference weight (PW) of days on which the blood glucose level is under control per week was the highest (1.41), and the PW of blood glucose monitoring frequency was the lowest (0.642). Patients were generally willing to pay for improvements in their type 2 diabetes mellitus (T2DM) treatment, and they had relatively higher WTP to avoid the blood glucose level within a normal value of 1 day/week (¥176.01) and also to avoid the frequency of hypoglycemic events within the range of 1–2/month (¥144.53). CONCLUSION: The number of days on which the blood glucose level is under control per week is the most important attribute in the treatment choice for patients with T2DM in China, followed by the frequency of hypoglycemic events, medication regimen, weight change, and blood glucose monitoring. Frontiers Media S.A. 2022-02-01 /pmc/articles/PMC8846300/ /pubmed/35178370 http://dx.doi.org/10.3389/fpubh.2021.782964 Text en Copyright © 2022 Huang, Huang, Xu, Lu and Xi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Huang, Yuankai
Huang, Qixiang
Xu, Ailin
Lu, Mengqing
Xi, Xiaoyu
Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
title Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
title_full Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
title_fullStr Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
title_full_unstemmed Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
title_short Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
title_sort patient preferences for diabetes treatment among people with type 2 diabetes mellitus in china: a discrete choice experiment
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846300/
https://www.ncbi.nlm.nih.gov/pubmed/35178370
http://dx.doi.org/10.3389/fpubh.2021.782964
work_keys_str_mv AT huangyuankai patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment
AT huangqixiang patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment
AT xuailin patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment
AT lumengqing patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment
AT xixiaoyu patientpreferencesfordiabetestreatmentamongpeoplewithtype2diabetesmellitusinchinaadiscretechoiceexperiment